Newly Diagnosed With Inflammatory Arthritis

Status Completed

Clinical Trial Summary

Even though medical treatment has improved within the last 10-15 years, patients with inflammatory arthritis (IA) still experience reduced quality of life, depression, anxiety, changes in family roles, work life, and social relationships. Particularly the newly diagnosed, require regular consultations and available support from health professionals, to be able to handle emotional, social, and physiological challenges. The hypothesis is that a self-management intervention can improve patients' ability to monitor their arthritis and respond to symptoms, reduce the risk of co-morbidities, and improve adherence. And also, that they can develop cognitive, behavioral, and emotional strategies to manage life with arthritis. There is a lack of disease-specific evidence, in integrated interventions with multiple components targeting patients with a newly diagnosed IA. In a previous study, the investigators developed a self-management intervention, and now wish to test it in a randomized feasibility study.

Clinical Trial Description

RATIONALE FOR NISMA PROJECT The hypothesis is that a self-management intervention can help patients develop behavioral and emotional strategies to manage life with arthritis. There a lack of disease-specific evidence, in integrated interventions with multiple components targeting patients with a newly diagnosed IA. Therefore, the investigators wish to develop a self-management intervention. Aim The overall aim of this study is to determine whether a full-scale randomized controlled trial, which aims to increase self-management in patients with newly diagnosed IA, is possible. The investigators wish to identify methodological, clinical, and procedural uncertainties in delivering a self-management intervention. Furthermore, to investigate outcomes related to recruitment, including adherence, retention, accrual rate, characteristics of the sample, and reliable recruitment methods. Design This feasibility study is designed as a randomized controlled feasibility trial (allocation ratio 1:1) to assess the proposed method in the definitive RCT. Overall Setting The intervention will take place at the Center for Rheumatology and Spine Diseases, Rigshospitalet, Denmark. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06063252
Study type	Interventional
Source	Glostrup University Hospital, Copenhagen
Contact
Status	Completed
Phase	N/A
Start date	November 1, 2021
Completion date	April 23, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05863559` - Super Chef - an Online Program Promoting the Mediterranean Dietary Pattern to Lower Income Families	N/A
Completed	`NCT04169724` - Meditation for Burnout in PA Students	N/A
Active, not recruiting	`NCT04505345` - Virtual Reality Cognitive Training in Alcohol Use Disorder	N/A
Completed	`NCT03286192` - Compassion Cultivation Training for Nurses	N/A
Recruiting	`NCT06322199` - Differences Between Suicide Attempters and Suicide Ideators. Influence of the Brief Therapy Attempted Suicide Short Intervention Program (ASSIP) on Neuropsychological Correlates and Psychological Process Factors - Project 3
Not yet recruiting	`NCT05790343` - Feasibility Study: Being a Parent - Helping Your Child With Fears and Worries
Terminated	`NCT05503810` - Social Support Intervention Targeting Patients Treated for Cardiac Disease Who Experience Loneliness	N/A
Completed	`NCT04150354` - Mental Health Symptom Monitoring Utilizing the Cogito Behavioral Analytic Platform	N/A
Completed	`NCT00557869` - Optimization of Cardiac-MR Protocols	N/A
Active, not recruiting	`NCT06175520` - Introduction of Preconception Care Through Public Health System for Improving MNCH&FP	N/A
Completed	`NCT06371248` - Steady Feet: Preventing Falls in the Community	N/A
Recruiting	`NCT05737823` - Supporting Family Carers' Mental Health	N/A
Terminated	`NCT03503968` - TCR Modified T Cells MDG1011 in High Risk Myeloid and Lymphoid Neoplasms	Phase 1/Phase 2
Not yet recruiting	`NCT04305990` - Demand-Driven Method for Gas Delivery in a Dental Setting	N/A
Completed	`NCT04553159` - Autologous Adipose Derived Stem Cells Transplantation in the Treatment of Keloids.	Phase 2
Completed	`NCT05697887` - Feasibility, Tolerability and Efficacy of the Ketogenic Diet in Children With Drug-resistant Epilepsy in South Vietnam	N/A
Completed	`NCT03237871` - The EMERGE Project: Feasibility of Assessing Economic and Sexual Risk Behaviors Using Text Messages in Young Adults	N/A
Active, not recruiting	`NCT01902238` - EUS-guided Ethanol-lipiodol Ablation of Pancreatic Neuroendocrine Tumor: a Prospective Study	N/A
Completed	`NCT01398059` - The Metabolic Effects of Breaks in Sedentary Time	N/A
Completed	`NCT03556878` - Implementing and Sustaining a Transdiagnostic Sleep and Circadian Treatment	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Newly Diagnosed With Inflammatory Arthritis - a Self-management Intervention (NISMA)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms